A novel peptide RIFV suppresses human adipocyte differentiation through the inhibition of C/EBP-β expression

BACKGROUND: Obesity is a global epidemic disease that increases the risk of metabolic syndrome. However, therapeutic drugs for obesity are still scarce. In recent years, peptides have been identified as new biological regulators. RIFV (R-I-F-V-P-I-K-G-R-P-A-P), a novel active peptide from our peptid...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nutr Metab (Lond)
Autors principals: Zhang, Wen, Shen, Dan, Li, Yun, Zhong, Hong, Wang, Xing, Cui, Xian-wei, Shi, Chun-Mei, Ji, Chen-Bo, Guo, Xi-Rong, Chen, Ling
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6929371/
https://ncbi.nlm.nih.gov/pubmed/31889968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-019-0414-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars